The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results

Randall J. Lee, Andy Hinson, Robert Bauernschmitt, Klaus Matschke, Qi Fang, Douglas L. Mann, Robert Dowling, Nelson Schiller, Hani N. Sabbah

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results'. Together they form a unique fingerprint.

Medicine & Life Sciences